This inventor holds 47 USPTO granted patents and 12 published patent applications, plus 13 CIPO patents and 13 EPO patents, primarily in Nucleic Acid Sequencing. Top assignees: Omniome, Inc., Illumina Corporation, Plexium, Inc.. Active years: 2014-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
16 out of 38 
11 out of 1,231 
11 out of 17 
Years Active: 2014-2026
Areas of Expertise:
Title: Innovating Genomic Sequencing: The Impact of Kandaswamy Vijayan
Introduction: Kandaswamy Vijayan is a prominent inventor based in San Diego, CA, who has made significant contributions to the field of genomic sequencing. With a remarkable portfolio consisting of 41 patents, Vijayan's innovative work is shaping the future of molecular biology and diagnostics.
Latest Patents: Among his notable patents, Vijayan has developed methods and apparatus that increase sequencing-by-binding efficiency. This invention involves a sophisticated method of determining nucleic acid sequences through the formation of ternary complexes using specific mixtures that include polymerase and nucleotide cognates. The process monitors signal states to accurately ascertain base calls, improving the reliability of sequence interpretations. Furthermore, Vijayan's invention of oligonucleotide-encoded chemical libraries focuses on a bead design that incorporates a covalently attached chemical compound and a DNA barcode. This innovative bead allows for the identification of chemical monomers and enables methods for sequencing and assessing the biological activity of the compounds.
Career Highlights: Kandaswamy Vijayan's career includes significant tenure at notable companies such as Omniome, Inc. and Illumina Corporation, where he contributed to advancements in genetic sequencing technologies. His work at these firms has empowered scientists and researchers to improve genomic analysis methods, thus enhancing the understanding of genetic information.
Collaborations: Throughout his career, Vijayan has collaborated with distinguished professionals including M Shane Bowen and Kevin L Gunderson. These partnerships have fostered a dynamic environment for innovation and facilitated the advancement of important research in the field of genomics.
Conclusion: Kandaswamy Vijayan exemplifies the spirit of innovation in biotechnology, with his patents paving the way for more efficient sequencing methods. His work not only reflects his expertise but also showcases the potential of collaboration in driving advancements within the scientific community. As the landscape of genomic technologies continues to evolve, the contributions of inventors like Vijayan will remain pivotal in shaping the future of biology and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile